Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LivSCP: Improving Liver Fibrosis Classification Through Supervised Contrastive Pretraining.

Diagnostics (Basel, Switzerland)·2025
Same author

Clinical image of rare primary oral melanoma in a paediatric patient.

BMJ case reports·2025
Same author

Explainable and Interpretable Model for the Early Detection of Brain Stroke Using Optimized Boosting Algorithms.

Diagnostics (Basel, Switzerland)·2024
Same author

Unlocking Precision Medicine for Prognosis of Chronic Kidney Disease Using Machine Learning.

Diagnostics (Basel, Switzerland)·2023

Related Experiment Video

Updated: Jun 3, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

947

Efficient Explainable Models for Alzheimer's Disease Classification with Feature Selection and Data Balancing

Yogita Dubey1, Aditya Bhongade1, Prachi Palsodkar2

  • 1Department of Electronics and Telecommunication, Yeshwantrao Chavan College of Engineering, Nagpur 441110, India.

Diagnostics (Basel, Switzerland)
|January 8, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a machine learning framework for early Alzheimer's disease diagnosis, achieving 95% accuracy. The interpretable model aids clinicians by highlighting key diagnostic features, improving patient management.

Keywords:
Alzheimer’s diseaseclassificationensemble learningexplainable AIfeature selectionquantitative evaluation

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

Related Experiment Videos

Last Updated: Jun 3, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

947
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

Area of Science:

  • Neuroscience
  • Artificial Intelligence
  • Medical Informatics

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia.
  • Early AD diagnosis is crucial but challenging due to disease complexity.
  • Clinical data is vital for AD classification, yet faces hurdles like data imbalance and high dimensionality.

Purpose of the Study:

  • To propose a computationally efficient, reliable, and transparent machine learning (ML) framework for AD patient classification.
  • To enhance model interpretability for medical practitioners to understand complex patient patterns.
  • To develop a system that aids in the early and accurate diagnosis of Alzheimer's disease.

Main Methods:

  • Employed ensemble learning (boosting algorithms) for improved classification accuracy.
  • Utilized random sampling for data balancing and feature selection/reduction for model optimization.
  • Integrated Explainable AI (XAI) tools (SHAP, LIME, ALE, ELI5) for model transparency and feature importance insights.

Main Results:

  • Achieved a robust, interpretable, and clinically relevant framework for AD diagnosis.
  • The proposed ML approach demonstrated a high accuracy of 95% in classifying Alzheimer's disease patients.
  • The framework effectively identified key clinical features influencing classification, enhancing diagnostic reliability.

Conclusions:

  • Integrating ensemble learning with XAI and balanced, feature-selected data significantly improves AD classification accuracy and interpretability.
  • This approach offers a promising tool for early and informed clinical decision-making in Alzheimer's disease.
  • The developed framework provides transparency, enabling clinicians to trust and understand the predictive factors for AD.